BACE1 and Alzheimer disease: It was found that the decrease in levels of miR-34a-5p and miR-125b-5p led to an increase in the expression of BACE1 in AD patients and cell cultures (MCN and N2a cells) that were treated with Aβ (Li et al., 2020).